MindWalk Holdings (HYFT) Cash & Equivalents (2020 - 2026)
MindWalk Holdings (HYFT) reported Cash & Equivalents of $10.1 million for Q1 2026, up 11.46% year-over-year from $9.1 million in Q1 2025, and down 14.79% quarter-over-quarter from $11.9 million in Q4 2025.
MindWalk Holdings (HYFT) Cash & Equivalents (2020 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has 7 years of Cash & Equivalents data on file, last reported at $10.1 million in Q1 2026.
- Cash & Equivalents for Q1 2026 came in at $10.1 million, up 11.46% year-over-year; the trailing twelve-month figure through Jan 2026 was $10.1 million (up 11.46% YoY), and the FY2025 annual result was $7.7 million, up 200.12% from the prior year.
- Cash & Equivalents slipped to $10.1 million in Q1 2026 per HYFT's latest filing, from $11.9 million in the prior quarter.
- Over five years, Cash & Equivalents peaked at $26.1 million in Q1 2022 and troughed at $2.6 million in Q2 2024.
- A 5-year average of $9.1 million and a median of $7.5 million in 2025 frame the typical range for Cash & Equivalents.
- The sharpest annual moves came in 2023 and 2025: Cash & Equivalents plunged 73.94% in 2023, then soared 359.84% in 2025.
- A 5-year view of Cash & Equivalents shows it stood at $11.3 million in 2022, then plunged by 60.86% to $4.4 million in 2023, then plunged by 41.68% to $2.6 million in 2024, then jumped by 359.84% to $11.9 million in 2025, then fell by 14.79% to $10.1 million in 2026.
- Business Quant data shows HYFT's Cash & Equivalents at $10.1 million in Q1 2026, $11.9 million in Q4 2025, and $3.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 32.30 Mn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 1.91 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 286.70 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 2.77 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | 18.44 Mn |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 7.15 Mn |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 5.49 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 558.94 Mn |
| 10 | MindWalk Holdings | 166.20 Mn | 156.06 Mn | 1.78 | 10.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 10.14 Mn |
| Oct 31, 2025 | 11.90 Mn |
| Jul 31, 2025 | 3.56 Mn |
| Apr 30, 2025 | 7.49 Mn |
| Jan 31, 2025 | 9.10 Mn |
| Oct 31, 2024 | 2.59 Mn |
| Jul 31, 2024 | 2.86 Mn |
| Apr 30, 2024 | 2.55 Mn |
| Jan 31, 2024 | 4.59 Mn |
| Oct 31, 2023 | 4.44 Mn |
| Jul 31, 2023 | 5.04 Mn |
| Apr 30, 2023 | 6.18 Mn |
| Jan 31, 2023 | 8.40 Mn |
| Oct 31, 2022 | 11.34 Mn |
| Jul 31, 2022 | 14.96 Mn |
| Apr 30, 2022 | 23.72 Mn |
| Jan 31, 2022 | 26.06 Mn |
| Oct 31, 2021 | 30.51 Mn |
| Jul 31, 2021 | 33.13 Mn |
| Apr 30, 2021 | 33.23 Mn |